Using Medications to Treat Epilepsy
John F. Kerrigan, M.D. Associate Professor of Child Health and Neurology
University of Arizona College of Medicine – Phoenix
Director, Pediatric Epilepsy Program and Clinical Neurophysiology Laboratory
Phoenix Children’s Hospital
Epilepsy Foundation of Arizona
Patient Education Conference
April 12, 2014
What is a Seizure?
An abnormal electrical discharge of neurons
in the brain
resulting in diverse symptoms
Seizure Classification
Single Event
Clinical Features and EEG
Focal or Partial
Simple
Complex
Secondarily Generalized
Generalized
Absence
Tonic
Atonic
Tonic-Clonic
Others
Epilepsy Syndrome Classification
Single Patient Includes All Clinical Information
Multiple Factors Age of Onset
Seizure Type or Types
EEG Pattern
Natural History
Associated Features
Others…
1-2
Years
2-6
Years
6-12
Years
>12
Years
3-12
Months
0-3
Months
Benign Neonatal
Seizures
Infantile
Spasms
Lennox-Gastaut
Syndrome
Benign Rolandic
Epilepsy
Juvenile Myoclonic
Epilepsy
Early Myoclonic
Encephalopathy
Childhood Absence
Epilepsy
phenytoin Dilantin
carbamazepine Tegretol
ethosuximide Zarontin
sodium valproate Depakote
felbamate Felbatol
gabapentin Neurontin
topiramate Topamax
lamotrigine Lamictal
zonisamide Zonegran levetiracetam
Keppra
oxcarbazepine Trileptal
Anti-Epilepsy Drugs (AEDs) 2014
pregabalin Lyrica
rufinamide Banzel
lacosamide Vimpat
vigabatrin Sabril ezogabine
Potiga
clobazam Onfi
Anti-Epilepsy Drugs (AEDs) 2014
But Wait, There’s More!
eslicarbazepine Aptiom
perampanel Fycompa
stiripentol Diacomit
GENERALIZED ONSET
Absence
Tonic-clonic
Myoclonic
Atonic
Tonic
PARTIAL ONSET
Simple
Complex
Secondary
Ethosuximide
Valproate
Carbamazepine
Phenytoin
Phenobarbital
Primidone
Benzodiazepines
1993
Use of Anti-Epilepsy Drugs (AEDs) 2014
Partial Onset
Generalized Onset
Simple
Complex
Secondary GTC
Absence
Tonic-Clonic
Myoclonic
Atonic/Tonic
Ethosuximide
Benzodiazepines
Levetiracetam
Valproic Acid
Felbamate
Lamotrigine
Topiramate
Zonisamide
Rufinamide
Vigabatrin
Clobazam
Stiripentol
Phenobarbital
Phenytoin
Carbamazepine
Gabapentin
Tiagabine
Oxcarbazepine
Pregabalin
Lacosamide
Ezogabine
Eslicarbazepine
Perampanel
Classification of Epilepsy Medications
Older Generation Medications
• More Side Effects
• More complex Drug-drug Interactions
Newer Generation Medications
• Less Side Effects
• Simpler Drug-Drug Interactions
• A Lot More Expensive!
Difference in anti-seizure effect is hard to measure.
Time One Day
Blood
Level
“Standard” Formulation Three Times A Day
“Peak”
Possible Dose-Related
Side Effects
“Trough”
Possible Increase
In Seizures
Neonate Infant Child Adult Elderly
Renal Function
Albumin
Hepatic Metabolism
CYPs
UGTs a orb
Anderson & Rho, in Wyllie, Treatment of Epilepsy, 4th Ed.
Dose-Related Side Effects
All Seizure Medications Can Cause … – Sleepiness
– Difficulty Concentrating
– Nausea, Vomiting
– Coordination Problems
– Double Vision
– Learning Issues
• Trouble Concentrating or Inattention
• Slowed Responses
• Difficulty Multitasking
…If the Dose Is Too High
Specific Side Effects - I
Serious Allergic Rash
Uncommon: Lamictal, Dilantin, Tegretol, Trileptal, Phenobarbital
Very Uncommon: Topamax, Zarontin, Zonegran
Almost Never: Keppra, Depakote, Benzodiazepines
Specific Side Effects - II
Serious Liver Problems
Uncommon: Depakote (Age <2 and Polytherapy)
Very Uncommon: Tegretol, Dilantin
Hematologic Problems
Depakote: decreased platelets
Tegretol > Trileptal: decreased white blood counts
Electrolyte Problems (Low Sodium)
Trileptal > Tegretol
Specific Side Effects - III
Weight Gain
Depakote, Neurontin, Lyrica
Weight Loss
Topamax, Zonegran, Felbatol
Anger/Behavior Problems
Keppra
Hyperactivity
Phenobarbital
Insomnia
Felbatol, Lamictal
Long-Term Side Effects
Liver Damage
No
Kidney Damage
No
Cancer
No
Decreased Bone Health
Yes!! For Some Medications
When are You a Good Candidate
For Epilepsy Surgery?
Seizures Always
Start in the
Same Place
or Area
That Place
or Area is
Safe
To Remove
And
2012 Annual Report, Cyberonics, Inc
Vagal Nerve Stimulation
FDA Approved 1997
Model 105 Introduced 2011
For Epilepsy Treatment
93,000 Systems Implanted
In 67,000 Patients
Revenue FY 2012
$219M
Epilepsy Treatment Algorithm
Yes No
Resective
Surgery
First Drug
Second Drug
Third Drug/Combination
Candidate for Surgical Resection?
Investigational
Medication VNS Ketogenic
Diet
47%
13%
5%
40-
80%
<5%
Drug Treatment for Epilepsy…
2014 and Beyond?
Brivaracetam
ICA-105665
2-Deoxy-Glucose Ganaxolone
Imepitoin NAX 810-2
Tonabersat VX-765 YKP3089
EILAT Conference 2012
Who Has Epilepsy?